Outcomes of Limbal Stem Cell Transplantation in Limbal Stem Cell Deficiency
Ahmed Bayoumy,
No information about this author
Mohamed Moustafa Rezk,
No information about this author
Amr Sharawy
No information about this author
et al.
Benha Medical Journal,
Journal Year:
2024,
Volume and Issue:
0(0), P. 0 - 0
Published: July 28, 2024
Purpose:
to
evaluate
the
surgical
outcomes
and
possible
complications
of
limbal
stem
cell
transplantation
procedures
including
keratolimbal
autograft
(KLAU)
transplantation
keratolimbal
allograft
(KLAL)
transplantation.Methods:
This
prospective
interventional
clinical
trial
included
"17
eyes"
patients
(with
mean
age
56.56
±7.53
years)
with
deficiency
(LSCD),
at
Benha
University
Hospitals,
in
between
May
2022
&
2024.Results:
The
obtained
results
this
study
showed
a
statistically
significant
difference
(improvement
VA)
pre-operative
post-operative
(after
3
Months)
visual
acuity
among
studied
eyes
(p-value
Language: Английский
Biomolecule-based hydrogels as delivery systems for limbal stem cell transplantation: A review
Fuyan Wang,
No information about this author
Yuehe Xu,
No information about this author
Qingjun Zhou
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
280, P. 135778 - 135778
Published: Sept. 18, 2024
Language: Английский
Short‐Peptide‐Induced Diffusion‐limited Plasmonic Aggregation with Broad Spectral Tunability for Wearable Ophthalmic Devices in Color Vision Deficiency Correction
Sheng Ran,
No information about this author
Yu‐Zhe Chen,
No information about this author
Haiyang He
No information about this author
et al.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 2, 2024
Abstract
Smart
wearable
ophthalmic
devices
such
as
contact
lenses
have
gained
widespread
interest
owing
to
their
compactness,
portability,
and
versatility
emerged
the
most
promising,
non‐invasive,
for
treatment
diagnosis
of
a
variety
ocular
diseases.
While
congenital
eye
diseases
color
vision
deficiency
(CVD)
are
reported,
they
show
limited
spectral
adjustment
range
unavailability
blocking
harmful
light
high‐energy
blue
(HEBL).
In
this
study,
silver
nanoparticle
(AgNP)
based
multifunctional
that
can
correct
various
types
CVDs
filter
out
developed.
AgNPs
controllably
assembled
via
short‐peptide‐induced
diffusion‐limited
aggregation
then
integrated
into
lenses.
By
varying
sequence
concentration
peptides,
extinction
value
nanoparticles
be
broadly
tuned
in
400–600
nm
range.
The
thus
wide
tunability
capable
efficiently
correcting
multiple
HEBL.
found
excellent
biocompatibility
with
cell
animal
tests.
conclusion,
provide
candidate
correction
CVD
protection
against
HEBL,
pave
way
personalized
devices.
Language: Английский